BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation

Yohann Loriot,Pierre Mordant,N. Dorvault,T. de La Motte Rouge,Jean Bourhis,J.C. Soria,Eric Deutsch

BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation

2010

Yohann Loriot
Pierre Mordant
N. Dorvault
T. de La Motte Rouge
Jean Bourhis
J.C. Soria
Eric Deutsch

BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation

Keywords:

Immunology
Cancer
Medicine
Cell
EGFR inhibitors
Epidermal growth factor receptor
Pathology
Biological activity
Lung cancer
Transplantation
Tyrosine-kinase inhibitor
T790M
Clonogenic assay
Vascular endothelial growth factor
Epidermal growth factor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations